SCHEMBL19080088

SCHEMBL19080088

c1ccc2cc(-c3c4ccccc4c(-c4ccc(-c5ccc6c(c5)c5ccccc5c5c6oc6ccc7ccccc7c65)c5ccccc45)c4ccccc34)ccc2c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 3/20 0.38
CYP1B1 Q16678 1/20 0.38
ARSA P15289 1/20 0.36
CDC25A P30304 1/20 0.36
CDC25C P30307 1/20 0.36
ABCG2 Q9UNQ0 3/20 0.34
CYP1A2 P05177 3/20 0.34
AHR P35869 3/20 0.34
PAX8 Q06710 2/20 0.34
NPC1 O15118 2/20 0.34
TDP1 Q9NUW8 2/20 0.34
FYN P06241 1/20 0.34
MAPK3 P27361 1/20 0.34
GPR84 Q9NQS5 1/20 0.34
RAB9A P51151 1/20 0.34
GSTP1 P09211 1/20 0.33
MIF P14174 1/20 0.32
MEN1 O00255 2/20 0.32
TP53 P04637 2/20 0.32
CYP2D6 P10635 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19080024 0.92 ABCG2 (0.40) CYP1A1CYP1B1ARSACDC25ACDC25C
SCHEMBL19080106 0.92 CYP1A1 (0.41) CYP1A1CYP1B1ARSACDC25ACDC25C
SCHEMBL19080093 0.92 CYP1A1 (0.39) CYP1A1CYP1B1ARSACDC25ACDC25C
SCHEMBL19080068 0.91 CYP1A1 (0.35) CYP1A1CYP1B1ARSACDC25ACDC25C
SCHEMBL19080054 0.91 ALOX5 (0.37) CYP1A1ARSACDC25ACDC25CABCG2
SCHEMBL17931968 0.90 GPR84 (0.36) CYP1A1CYP1B1ARSACDC25ACDC25C
SCHEMBL19079995 0.90 CYP1A1 (0.40) CYP1A1CYP1B1ARSACDC25ACDC25C
SCHEMBL19080085 0.89 CYP1A1 (0.35) CYP1A1CYP1B1ARSACDC25ACDC25C
SCHEMBL19080090 0.87 CYP1A1 (0.43) CYP1A1CYP1B1ARSACDC25ACDC25C
SCHEMBL19080041 0.87 CYP1A1 (0.41) CYP1A1CYP1B1ABCG2CYP1A2AHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-03-03 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNA1 CYP1A1 147/4885CYP1B1 225/4885ARSA 4452/4885
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNA1 CYP1A1 147/4885CYP1B1 225/4885ARSA 4452/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.